TABLE 5.
Effect of the phenyl-thiazolylurea-sulfonamides on the susceptibility of a relA+ strain and its isogenic strain carrying a relA mutationlegend
| Compound or drug | MIC (μg/ml)
|
|
|---|---|---|
| E. coli CP78 | E. coli CP79 | |
| 1 | 0.78 | 0.05 |
| 2 | 0.39 | 0.1 |
| 3 | 0.2 | 0.003 |
| 4 | 0.39 | 0.05 |
| 5 | 0.78 | 0.2 |
| 6 | 0.2 | 0.012 |
| 7 | 0.2 | 0.006 |
| Mupirocin | 0.2 | 0.05 |
| Chloramphenicol | 0.1 | 0.1 |
| Kanamycin | 0.05 | 0.05 |
| Erythromycin | 0.003 | 0.003 |
| Tetracycline | 0.05 | 0.05 |
| Rifampicin | 0.0008 | 0.0008 |
| Cerulenin | 0.05 | 0.05 |
aMICs were compared for the relA+ strain E. coli CP78, which is able to induce the stringent response cascade, versus the isogenic relA CP79, which is not. The culture broth was supplemented with polymyxin B nonapeptide to facilitate passage of the compounds across the outer membrane. In the absence of polymyxin B nonapeptide, no activity was detected for the phenyl-thiazolylurea-sulfonamides.